Sun Xue-Mei, Chen Jun-Hao, Xu Jing-Yan, Zhang Yi-Fen, Xie Pin-Hao, Fan Xun-Nan, Xie Wie
Genetic Research Center, Basic Medical College, South East University, Nanjing, Jiangsu, 210009, PR China.
Ai Zheng. 2004 Aug;23(8):955-7.
BACKGROUND & OBJECTIVE: Multiple parameter immunophenotype analysis by flow cytometry (FCM) could improve the accuracy of diagnosis in lymphoproliferative diseases. This study was to analyze the immunophenotype of 135 samples, including lymph nodes, blood, bone marrow, and cerebrospinal fluid samples, from 121 patients with suspected lymphoid malignancies, to evaluate its role in diagnosis.
All samples were tested by routine morphological, pathological, and immunohistochemical methods, and analyzed by FCM in suspended single cells, to compare the accuracy of different diagnostic methods.
(1) Three of 23 lymph nodes, which failed to be diagnosed by routine methods, were determined by flow cytometric immunophenotype analysis. (2) According to new WHO classification, 96 of 97 blood or bone marrow aspiration samples were diagnosed by flow cytometric immunophenotype analysis, while 88 of 97 samples were diagnosed by routine immunohistochemical method. (3) Multiple parameter immunophenotype analysis in cerebrospinal fluid samples by FCM improved the diagnostic accuracy of leukemia or lymphoma involvement of central nervous system.
Multiple parameter immunophenotype analysis by FCM improves the accuracy of diagnosis in lymphoid malignancies, and can be used in diagnosis, differentiated diagnosis, and detection of minimal residue in lymphoproliferative diseases.
流式细胞术(FCM)多参数免疫表型分析可提高淋巴增殖性疾病的诊断准确性。本研究旨在分析121例疑似淋巴系统恶性肿瘤患者的135份样本(包括淋巴结、血液、骨髓和脑脊液样本)的免疫表型,以评估其在诊断中的作用。
所有样本均采用常规形态学、病理学和免疫组织化学方法检测,并在悬浮单细胞中进行FCM分析,以比较不同诊断方法的准确性。
(1)23个经常规方法未能诊断的淋巴结样本中,有3个通过流式细胞术免疫表型分析得以确诊。(2)根据世界卫生组织(WHO)新分类标准,97份血液或骨髓穿刺样本中有96份通过流式细胞术免疫表型分析确诊,而97份样本中有88份通过常规免疫组织化学方法确诊。(3)FCM对脑脊液样本进行多参数免疫表型分析提高了白血病或淋巴瘤累及中枢神经系统的诊断准确性。
FCM多参数免疫表型分析提高了淋巴系统恶性肿瘤的诊断准确性,可用于淋巴增殖性疾病的诊断、鉴别诊断及微小残留检测。